Today: 20 May 2026
GE Vernova stock slips after hours as 2025 ends; dividend date and January earnings in focus
1 January 2026
2 mins read

GE Vernova stock slips after hours as 2025 ends; dividend date and January earnings in focus

NEW YORK, December 31, 2025, 18:41 ET — After-hours

  • GE Vernova shares were down about 0.9% after the bell, tracking a weak year-end tape.
  • Investors are looking to the Jan. 5 dividend record date and late-January earnings timing.
  • Peer grid and power-infrastructure names also edged lower in late trading.

GE Vernova Inc. shares fell in after-hours trading on Wednesday, down 0.9% at $653.57 by 6:41 p.m. ET, or $6.19 below Tuesday’s close. The stock traded between $647.71 and $666.30 during the day, with about 1.26 million shares changing hands.

The slide underscores how sensitive the stock has become to year-end positioning after a sharp run tied to rising electricity demand and data-center buildouts. GE Vernova’s shares have risen more than 370% since the company was spun off from General Electric in 2024, Reuters reported earlier this month.

With U.S. markets closed on Thursday for New Year’s Day and reopening on Friday, Jan. 2, investors used the final session of 2025 to reduce risk and lock in gains. Traders are also lining up January catalysts, including the next earnings update and the company’s newly increased dividend timeline.

Wall Street ended the year’s final session lower in holiday-thin trade, with the S&P 500 down 0.74%, the Nasdaq off 0.76% and the Dow down 0.63%, according to Reuters.

Other U.S. companies linked to grid spending and power demand also eased in late trading, including Eaton, Quanta Services, Hubbell and Generac, down roughly 0.6% to 1.6%.

GE Vernova last month raised its medium-term outlook at an investor update, as it flagged long-cycle demand for power equipment. CEO Scott Strazik said, “Electric power will be critical to unlocking economic growth in the decades ahead,” and the company forecast 2026 revenue of $41 billion to $42 billion, with an adjusted EBITDA margin — a profit measure before interest, taxes and some one-offs — of 11% to 13%. It also guided to $4.5 billion to $5.0 billion of free cash flow, or cash left after costs and capital spending, and pointed to “slot reservation agreements,” which reserve manufacturing capacity for future gas-turbine deliveries. GE Vernova

The board also doubled the quarterly dividend to $0.50 a share and raised the share repurchase authorization to $10 billion, the company said. The dividend is payable Feb. 2 to shareholders of record as of Jan. 5.

Even after Wednesday’s slip, the stock remains within its recent range, about 11% below its 52-week high of $731 and far above its 52-week low of $252.25, MarketWatch data showed.

Sell-side targets still imply upside, but they also highlight the valuation debate around the name. MarketWatch data showed an average target price of about $753, with estimates ranging from $485 to $1,000.

The next major check-in will be fourth-quarter results and any update to 2026 demand and margin assumptions. GE Vernova has not announced a reporting date, and Nasdaq’s earnings page lists Jan. 28 as an estimated report date derived from an algorithm.

Into early 2026, investors are likely to focus on order intake in the Power and Electrification units, delivery timing across constrained equipment categories, and signs that data-center-related demand is translating into booked revenue. Updates on wind profitability remain a swing factor for sentiment.

Technically, traders are watching the $650 area after the stock tested it on Wednesday. Holding that level could keep attention on the upper end of the recent range, while a decisive break would shift focus to the next support band from earlier in December.

Stock Market Today

  • Sensex and Nifty Poised for Lower Open Amid Crude Rise and Geopolitical Tensions
    May 20, 2026, 1:21 AM EDT. Indian stock markets are expected to open lower on the back of rising crude oil prices, higher U.S. Treasury yields, and escalating tensions involving Iran. These factors are dampening investor sentiment. Additionally, persistent foreign portfolio selling, elevated market volatility, and critical technical support levels are causing traders to remain cautious ahead of the session.

Latest articles

Wall Street Hit by Yield Jolt With Nvidia Up Next

Wall Street Hit by Yield Jolt With Nvidia Up Next

20 May 2026
U.S. stock ETFs remained lower late Tuesday after Wall Street’s main indexes fell for a third straight session, pressured by rising Treasury yields and caution ahead of Nvidia’s earnings. The SPDR S&P 500 ETF dropped 0.7% to $733.73. The 10-year Treasury yield hit 4.687%, its highest since January 2025, before easing. Nvidia shares slipped 0.7% after hours, with traders bracing for a major move post-earnings.
Viavi Stock Drops After $500 Million Share Sale Plan — The Debt Move Investors Can’t Ignore

Viavi Stock Drops After $500 Million Share Sale Plan — The Debt Move Investors Can’t Ignore

20 May 2026
Viavi Solutions shares dropped 7.1% in after-hours trading Tuesday after the company announced a $500 million public stock offering aimed at repaying debt. The offering, unveiled just after the Nasdaq close, could add roughly 10.1 million new shares. Viavi plans to use proceeds to pay down a $450 million loan. Total debt would fall to $650 million, according to a preliminary SEC filing.
Analog Devices Shares Rally After $1.5B AI Power Deal Ahead of Earnings

Analog Devices Shares Rally After $1.5B AI Power Deal Ahead of Earnings

20 May 2026
Analog Devices agreed to acquire Empower Semiconductor for $1.5 billion in cash, sending ADI shares up 1.36% to $419.95 in after-hours trading after closing down 1.02%. The deal, approved by both boards, is expected to close in the second half of 2026 pending regulatory review. Empower CEO Tim Phillips will continue to lead integrated voltage regulator work after the merger.
AI stocks today: Nvidia, AMD tick higher as year-end trade turns cautious
Previous Story

AI stocks today: Nvidia, AMD tick higher as year-end trade turns cautious

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD
Next Story

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD

Go toTop